ExodusPoint Capital Management, LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$109,000
+101.9%
16,198
+26.8%
0.00%0.0%
Q2 2021$54,00012,7720.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 1,817,138$30,582,0002.98%
SENZAR ASSET MANAGEMENT, LLC 29,821$502,0001.45%
INGALLS & SNYDER LLC 1,337,862$22,516,0001.04%
Matarin Capital Management, LLC 316,858$5,332,720,0000.39%
KNOTT DAVID M 51,557$868,0000.32%
PRINCETON CAPITAL MANAGEMENT LLC 16,582$279,0000.12%
GSA CAPITAL PARTNERS LLP 123,700$2,082,0000.10%
Spark Investment Management LLC 97,200$1,635,0000.10%
ACADIAN ASSET MANAGEMENT LLC 941,282$15,841,0000.07%
Municipal Employees' Retirement System of Michigan 67,220$1,131,0000.06%
View complete list of CONCERT PHARMACEUTICALS INC shareholders